Moderna Inc, the COVID-19, coronavirus vaccine maker, still holds at very high, large market capitalization level of 48.4 billion USD, despite the mainstream media not reporting so much on the COVID-19, coronavirus pandemic, implying the coronavirus has been defeated.
The COVID-19, coronavirus pandemic is not over is Wolfteam Ltd.'s corporate opinion.
The COVID-19, coronavirus simply adapts too well to adversity and treatment, impediments. COVID-19, coronavirus' illness still lingers and people still lose their lives in hospitals' emergency wards after loosing the battle with COVID-19, coronavirus.
Most have read the media reports, including CIA's investigations that the COVID-19, coronavirus (could be) is a laboratory experiment, which was "leaked". And these are not conspiracy theories, but official statements by government agencies, be it in a vaguely written form.
That said, according to Wolfteam Ltd.'s valuation, Moderna Inc is undervalued long-term. Not only does Moderna Inc produce the leading vaccine for COVID-19, coronavirus, but it also produces vaccines for cancer, which if successful en masse could increase Moderna Inc's market capitalization to 1 trillion USD.
In addition, Moderna Inc has been developing the messengerRNA, mRNA technology for 15 leaders. mRNA is arguably the most valuable biotechnology and essential for the preservation of humanity's health. Moderna Inc's patents are invaluable and Moderna has a significant advantage over its competitors in knowledge, patents, skilled workforce and speed, of course
Simply said, Moderna Inc looks like an extremely valuable, under-priced call option on the future of humanity is Wolfteam Ltd.'s corporate opinion.
www.wolfteamedge.com
No comments:
Post a Comment